BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15(39): 4962-4968 [PMID: 19842230 DOI: 10.3748/wjg.15.4962]
URL: https://www.wjgnet.com/1007-9327/full/v15/i39/4962.htm
Number Citing Articles
1
Alberto Di Leo, Andrea Zanoni. Siewert III adenocarcinoma: treatment updateUpdates in Surgery 2017; 69(3): 319 doi: 10.1007/s13304-017-0429-9
2
Kfir Ben-David, George A. Sarosi, Juan C. Cendan, Drew Howard, Georgios Rossidis, Steven N. Hochwald. Decreasing morbidity and mortality in 100 consecutive minimally invasive esophagectomiesSurgical Endoscopy 2012; 26(1): 162 doi: 10.1007/s00464-011-1846-3
3
Felice Pasini, Anna Paola Fraccon, Giovanni de Manzoni. Treatment of Esophageal and Hypopharyngeal Squamous Cell CarcinomaUpdates in Surgery 2012; : 131 doi: 10.1007/978-88-470-2330-7_12
4
MICHELE ORDITURA, GENNARO GALIZIA, ALESSIO FABOZZI, EVA LIETO, VALENTINA GAMBARDELLA, FLORIANA MORGILLO, GIAN MATTIA DEL GENIO, LANDINO FEI, NATALE DI MARTINO, ANDREA RENDA, FORTUNATO CIARDIELLO, FERDINANDO DE VITA. Preoperative treatment of locally advanced esophageal carcinomaInternational Journal of Oncology 2013; 43(6): 1745 doi: 10.3892/ijo.2013.2118
5
Maxim Le Compte, Niels Komen, Ines Joye, Marc Peeters, Hans Prenen, Evelien Smits, Christophe Deben, Michiel de Maat. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignanciesCritical Reviews in Oncology/Hematology 2021; 157: 103190 doi: 10.1016/j.critrevonc.2020.103190
6
Suun Sathornviriyapong, Akihisa Matsuda, Masao Miyashita, Satoshi Matsumoto, Nobuyuki Sakurazawa, Yoichi Kawano, Marina Yamada, Eiji Uchida. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysisAnnals of Surgical Oncology 2016; 23(11): 3632 doi: 10.1245/s10434-016-5298-9
7
Bernhard J. Leibl, Stephanie Vitz, Wolfgang Schäfer, Martin Alfrink, Andreas Gschwendtner, Gerhard G. Grabenbauer. Adenocarcinoma of the esophagogastric junction: Neoadjuvant radiochemotherapy and radical surgeryStrahlentherapie und Onkologie 2011; 187(4): 231 doi: 10.1007/s00066-011-2171-4
8
M.C.C.M. Hulshof, H.W.M. van Laarhoven. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junctionBest Practice & Research Clinical Gastroenterology 2016; 30(4): 551 doi: 10.1016/j.bpg.2016.06.002
9
Fang Li, Tao Li, Li Liu, Jiahua Lv, Yanqiong Song, Churong Li, Peng Diao. Concurrent versus Sequential Chemoradiotherapy for Esophageal Cancer among Chinese Population: A Meta-AnalysisTumori Journal 2015; 101(4): 353 doi: 10.5301/tj.5000314
10
Junko Kuroda, Masashi Yoshida, Masaki Kitajima, Akio Yanagisawa, Toshiki Matsubara, Toshiharu Yamaguchi, Yoshiyuki Osamura, Keiichirou Ohta, Keisuke Kubota, Yoshifumi Beck, Yuichi Yamashita. Utility of preoperative chemoradiotherapy for advanced esophageal carcinomaJournal of Gastroenterology and Hepatology 2012; 27(s3): 88 doi: 10.1111/j.1440-1746.2012.07078.x
11
Priyanka Sethi, B D Vaishnavi, Manbir Kaur, Tanvi Meshram. Unexpected aortic tearSaudi Journal of Anaesthesia 2022; 16(1): 140 doi: 10.4103/sja.sja_730_21
12
JUN SOBAJIMA, KENSUKE KUMAMOTO, NORIHIRO HAGA, JUNICHI TAMARU, TAKEO TAKAHASHI, TATSUYA MIYAZAKI, HIDEYUKI ISHIDA. Early evaluation of the apoptotic index ratio is useful in predicting the efficacy of chemoradiotherapy in esophageal squamous cell carcinomaOncology Letters 2012; 3(2): 287 doi: 10.3892/ol.2011.468
13
N. Schuring, W.T. Stam, V.D. Plat, M.C. Kalff, M.C.C.M. Hulshof, H.W.M. van Laarhoven, S. Derks, D.L. van der Peet, M.I. van Berge Henegouwen, F. Daams, S.S. Gisbertz. Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral centerEuropean Journal of Surgical Oncology 2023; 49(10): 106947 doi: 10.1016/j.ejso.2023.05.022
14
A. Zanoni, G. Verlato, S. Giacopuzzi, J. Weindelmayer, F. Casella, F. Pasini, E. Zhao, G. de Manzoni. Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume CenterAnnals of Surgical Oncology 2013; 20(6): 1993 doi: 10.1245/s10434-012-2822-4
15
Su Q. Li, He M. Wang, Xiu F. Cao. Potential clinical insights into microRNAs and their target genes in esophageal carcinomaBiomarkers 2011; 16(8): 629 doi: 10.3109/1354750X.2011.608132
16
Pierfrancesco Franco, Francesca Arcadipane, Paolo Strignano, Rosella Spadi, Elisabetta Trino, Stefania Martini, Giuseppe Carlo Iorio, Maria Antonietta Satolli, Mario Airoldi, Renato Romagnoli, Michele Camandona, Umberto Ricardi. Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trialsMedical Oncology 2017; 34(3) doi: 10.1007/s12032-017-0898-1
17
Hyun Chang, Sung Kwan Shin, Byoung Chul Cho, Chang-Geol Lee, Choong Bai Kim, Dae Joon Kim, Jin Gu Lee, Jin Hur, Chang Young Lee, Mi Kyung Bae, Hye Ryun Kim, Sang Kil Lee, Jun Chul Park, Hyuk Lee, Hyoung-Il Kim, Hyunsoo Chung, Jihye Cha, Yong Chan Lee, Joo-Hang Kim. A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancerCancer Chemotherapy and Pharmacology 2014; 73(4): 665 doi: 10.1007/s00280-013-2371-y
18
Amit Javed, Sujoy Pal, Gaurav Nitin Chaubal, Peush Sahni, Tushar Kanti Chattopadhyay. Management and Outcome of Intrathoracic Bleeding due to Vascular Injury During Transhiatal EsophagectomyJournal of Gastrointestinal Surgery 2011; 15(2): 262 doi: 10.1007/s11605-010-1375-8
19
Kfir Ben-David, George Rossidis, Robert A. Zlotecki, Stephen R. Grobmyer, Juan C. Cendan, George A. Sarosi, Steven N. Hochwald. Minimally Invasive Esophagectomy is Safe and Effective Following Neoadjuvant Chemoradiation TherapyAnnals of Surgical Oncology 2011; 18(12): 3324 doi: 10.1245/s10434-011-1702-7
20
Heidi Furlong, Gary Bass, Oscar Breathnach, Brian O'Neill, Eamonn Leen, Thomas N. Walsh. Targeting therapy for esophageal cancer in patients aged 70 and overJournal of Geriatric Oncology 2013; 4(2): 107 doi: 10.1016/j.jgo.2012.12.006
21
Valdir Tercioti Jr, Luiz Roberto Lopes, João de Souza Coelho-Neto, Nelson Adami Andreollo. Terapêutica neo-adjuvante aumenta as complicações pós-operatórias da esofagectomia?ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2010; 23(3): 168 doi: 10.1590/S0102-67202010000300008
22
Nida Akgul, Abdullah Sakin, Suleyman Sahin, Mehmet Naci Aldemir, Aydin Aytekin, Murat ALAY, Umit Haluk Iliklerden, Mehmet Cetin Kotan. Factors Affecting Survival in Operated Esophageal Squamous Cell CarcinomaJournal of Gastrointestinal Cancer 2022; 53(2): 439 doi: 10.1007/s12029-021-00631-z
23
F De Vita, M Orditura, E Martinelli, L Vecchione, R Innocenti, V C Sileni, C Pinto, M Di Maio, A Farella, T Troiani, F Morgillo, V Napolitano, E Ancona, N Di Martino, A Ruol, G Galizia, A Del Genio, F Ciardiello. A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancerBritish Journal of Cancer 2011; 104(3): 427 doi: 10.1038/sj.bjc.6606093
24
Alexandra D. Dreyfuss, Anastasia Velalopoulou, Harris Avgousti, Brett I. Bell, Ioannis I. Verginadis. Preclinical models of radiation-induced cardiac toxicity: Potential mechanisms and biomarkersFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.920867
25
Grzegorz Ćwik, Andrzej Dąbrowski, Tomasz Skoczylas, Grzegorz Wallner. Imaging of the Cervical and Abdominal Lymph Nodes in a Combined Treatment of Squamous Cell Oesophageal CarcinomaPolish Journal of Surgery 2011; 83(2) doi: 10.2478/v10035-011-0015-7
26
Jianhao Qiu, Zhan Zhang, Junjie Liu, Yue Zhao, Yongmeng Li, Zhanpeng Tang, Lin Li, Yu Tian, Hui Tian. Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapyWorld Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03474-7
27
E Tanaka, H Okabe, S Tsunoda, K Obama, T Kan, Y Kadokawa, M Akagami, Y Sakai. Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapyAsian Journal of Endoscopic Surgery 2012; 5(3): 111 doi: 10.1111/j.1758-5910.2012.00131.x
28
Pankaj Kumar Garg, Jyoti Sharma, Ashish Jakhetiya, Aakanksha Goel, Manish Kumar Gaur. Preoperative therapy in locally advanced esophageal cancerWorld Journal of Gastroenterology 2016; 22(39): 8750-8759 doi: 10.3748/wjg.v22.i39.8750
29
SUSUMU SAIGUSA, KOJI TANAKA, MASAKI OHI, YUJI TOIYAMA, HIROMI YASUDA, TAKAHITO KITAJIMA, YOSHINAGA OKUGAWA, YASUHIRO INOUE, YASUHIKO MOHRI, MASATO KUSUNOKI. Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapyMolecular and Clinical Oncology 2015; 3(1): 151 doi: 10.3892/mco.2014.431
30
Ali Sadrizadeh, Reza Bagheri, Ehsan Soltani, Kazem Anvari, Mehdi Seilanian Toussi, Soheila Moadikhah. The Comparison of the Advantages of Neoadjuvant Chemoradiotherapy versus Postoperative Chemoradiotherapy: Outcomes in Esophageal Cancer PatientsJournal of Gastrointestinal Cancer 2018; 49(1): 50 doi: 10.1007/s12029-016-9899-0
31
K. Maruyama, S. Motoyama, A. Anbai, S. Usami, Y. Sato, K. Shibuya, K. Yoshino, T. Nakatsu, Y. Minamiya, J.-I. Ogawa. Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapyDiseases of the Esophagus 2011; 24(3): 166 doi: 10.1111/j.1442-2050.2010.01119.x
32
Giovanni de Manzoni, Andrea Zanoni, Jacopo Weindelmayer. Treatment of Esophageal and Hypopharyngeal Squamous Cell CarcinomaUpdates in Surgery 2012; : 161 doi: 10.1007/978-88-470-2330-7_14
33
A.M. Reece‐Smith, S. Saha, M.L. Cunnell, K. Hameed, E.M. Bessell, J.P. Duffy, S. Madhusudan, S.L. Parsons. MAGIC in practice: Experience of peri‐operative ECF/X chemotherapy in gastro‐esophageal adenocarcinomasJournal of Surgical Oncology 2012; 106(6): 748 doi: 10.1002/jso.23187
34
J. Huang, S.‐Y. Zhang, Y.‐M. Gao, Y.‐F. Liu, Y.‐B. Liu, Z.‐G. Zhao, K. Yang. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targetsCell Proliferation 2014; 47(4): 277 doi: 10.1111/cpr.12109
35
Katrin Schwameis, Joerg Zehetner, Jeffrey A. Hagen, Daniel S. Oh, Stephanie G. Worrell, Kais Rona, Nathan Cheng, Jamil Samaan, Kyle M. Green, John C. Lipham. Esophageal adenocarcinoma stage III: Survival based on pathological response to neoadjuvant treatmentSurgical Oncology 2017; 26(4): 522 doi: 10.1016/j.suronc.2017.10.001
36
K Kumagai, I Rouvelas, J A Tsai, D Mariosa, F Klevebro, M Lindblad, W Ye, L Lundell, M Nilsson. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancersBritish Journal of Surgery 2014; 101(4): 321 doi: 10.1002/bjs.9418
37
Xiaowu Zhong, Guangcheng Huang, Qiang Ma, Hebin Liao, Chang Liu, Wenjie Pu, Lei Xu, Yan Cai, Xiaolan Guo. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysisMedicine 2019; 98(27): e16269 doi: 10.1097/MD.0000000000016269
38
Arzu Oezcelik, Gernot M. Kaiser, Wolfgang Niebel, Christopher Sleyman, Juergen W. Treckmann, Georgios C. Sotiropoulos, Renate Reinhardt, Tanja Trarbach, Eugen Malamutmann, Andreas Paul. Ten‐year survival of esophageal cancer after an en‐bloc esophagectomyJournal of Surgical Oncology 2012; 105(3): 284 doi: 10.1002/jso.22096
39
Jin Zhou, Hai-Ping Lin, Xin Xu, Xiao-Hang Wang, Ling Rong, Yao Zhang, Lei Shen, Lei Xu, Wei-Ting Qin, Qing Ye, Xiu-Mei Ma, Yong-Rui Bai. The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapyFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1041126
40
B. Mungo, D. Molena, M. Stem, S. C. Yang, R. J. Battafarano, M. V. Brock, A. O. Lidor. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?Diseases of the Esophagus 2015; 28(7): 644 doi: 10.1111/dote.12251
41
Thomas Steffen, Daniel Dietrich, Annelies Schnider, Christoph Kettelhack, Olivier Huber, Walter R. Marti, Markus Furrer, Beat Gloor, Marc Schiesser, Sandra Thierstein, Peter Brauchli, Thomas Ruhstaller. Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal CancerAnnals of Surgery 2019; 269(1): 83 doi: 10.1097/SLA.0000000000002435
42
Florian Sterzing, Lars Grenacher, Jürgen Debus. Early Gastrointestinal CancersRecent Results in Cancer Research 2012; 196: 187 doi: 10.1007/978-3-642-31629-6_13
43
Tad Kim, Stephen R Grobmyer, Reshelle Smith, Kfir Ben‐David, Darwin Ang, Stephen B Vogel, Steven N Hochwald. Esophageal cancer—the five year survivorsJournal of Surgical Oncology 2011; 103(2): 179 doi: 10.1002/jso.21784
44
Charles Bakhos, Tolutope Oyasiji, Nassrene Elmadhun, Michael Kent, Sidhu Gangadharan, Jonathan Critchlow, Tom Fabian. Feasibility of Minimally Invasive Esophagectomy After Neoadjuvant ChemoradiationJournal of Laparoendoscopic & Advanced Surgical Techniques 2014; 24(10): 688 doi: 10.1089/lap.2014.0118
45
Christoph Pöttgen, Martin Stuschke. Radiotherapy versus surgery within multimodality protocols for esophageal cancer – A meta-analysis of the randomized trialsCancer Treatment Reviews 2012; 38(6): 599 doi: 10.1016/j.ctrv.2011.10.005
46
Koichi Hayano, Kiyohiko Shuto, Asami Satoh, Tomoyoshi Aoyagi, Kazuo Narushima, Hisashi Gunji, Tsuguaki Kono, Noriyuki Yanagawa, Shinichi Okazumi, Hisahiro Matsubara. Tumor blood flow change measured by CT perfusion during chemoradiation therapy (CRT) for monitoring response and predicting survival in patients with esophageal cancerEsophagus 2014; 11(1): 72 doi: 10.1007/s10388-013-0400-x
47
Susumu Saigusa, Koji Tanaka, Masaki Ohi, Yoshito Ishino, Hiromi Yasuda, Yoshinaga Okugawa, Yuji Toiyama, Yasuhiro Inoue, Keiichi Uchida, Yasuhiko Mohri, Masato Kusunoki. Clinical significance of peritumoral mast cells in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapyEsophagus 2013; 10(1): 12 doi: 10.1007/s10388-012-0356-2
48
Andrea Zanoni, Giuseppe Verlato, Simone Giacopuzzi, Massimiliano Motton, Francesco Casella, Jacopo Weindelmayer, Elena Ambrosi, Alberto Di Leo, Antonios Vassiliadis, Francesco Ricci, Thomas W. Rice, Giovanni de Manzoni. ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal CancerAnnals of Surgical Oncology 2016; 23(S5): 998 doi: 10.1245/s10434-016-5440-8
49
Shenglei Li, Hongtao Liu, Changying Diao, Xiaohui Wang, Ming Gao, Zongming Li, Lijie Song, Xianzheng Gao, Jing Han, Feng Wang, Wencai Li, Xinwei Han. Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysisOncotarget 2017; 8(22): 36339 doi: 10.18632/oncotarget.16193
50
Nazim Bhimani, David Mitchell, Cameron Law, Steven Leibman, Garett Smith. Perioperative outcomes in patients who undergo neoadjuvant chemoradiotherapy versus chemotherapy versus up‐front surgery in patients with oesophageal cancerANZ Journal of Surgery 2024; 94(10): 1715 doi: 10.1111/ans.19159
51
M. Stahl, T. Ruhstaller. Multimodale Therapie des ÖsophaguskarzinomsDer Internist 2014; 55(1): 7 doi: 10.1007/s00108-013-3315-7
52
Andrea Zanoni, Simone Giacopuzzi, Silvia Laiti, Alberto Di Leo, Giovanni de Manzoni. Adenocarcinoma of the Esophagogastric Junction2017; : 117 doi: 10.1007/978-3-319-28776-8_14
53
Kristen Jogerst, Chi Zhang, Yu-Hui Chang, Nikita Gupta, Chee-Chee Stucky, Jonathan D’Cunha, Nabil Wasif. Dynamic volume-outcome association for esophagectomies: Do current volume thresholds still apply?Surgery 2024; 176(2): 341 doi: 10.1016/j.surg.2024.04.010
54
M. Orditura, G. Galizia, F. Morgillo, E. Martinelli, E. Lieto, F. Vitiello, N. Di Martino, R. Pacelli, A. Renda, F. Ciardiello, F. De Vita. Complete response to preoperative chemoradiation and survival in esophageal cancer: a pooled analysis of three single-institution phase II trialsDiseases of the Esophagus 2012; 25(2): 130 doi: 10.1111/j.1442-2050.2011.01220.x
55
Dong-Bin Wang, Xun Zhang, Hong-Li Han, Yi-Jun Xu, Da-Qiang Sun, Zhen-Liang Shi. Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-AnalysisDigestive Diseases and Sciences 2012; 57(12): 3226 doi: 10.1007/s10620-012-2263-8
56
Khashayar Fakhrian, Arif Deniz Ordu, Florian Lordick, Jörg Theisen, Bernhard Haller, Tomislav Omrčen, Michael Molls, Carsten Nieder, Hans Geinitz. Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FUStrahlentherapie und Onkologie 2014; 190(12): 1133 doi: 10.1007/s00066-014-0711-4
57
Johannes Zacherl. The Current Evidence in Support of Multimodal Treatment of Locally Advanced, Potentially Resectable Esophageal CancerDigestive Diseases 2014; 32(1-2): 171 doi: 10.1159/000357189
58
Xin Nie, Shuya He, Xinming Nie, Changding Li, Kunyi Du, Wenwu He, Zhiyu Li, Kunhan Ni, Simiao Lu, Chenghao Wang, Kangning Wang, Yan Miao, Longlin Jiang, Jiahua Lv, Guangyuan Liu, Qiang Fang, Lin Peng, Wenguang Xiao, Qifeng Wang, Dongsheng Wang, Yongtao Han, Xuefeng Leng. Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1320282
59
C. Pöttgen, M. Stuschke. Multimodale Therapie beim Plattenepithelkarzinom des ÖsophagusDer Onkologe 2010; 16(5): 496 doi: 10.1007/s00761-010-1829-3